Discovery of Trypanosoma brucei inhibitors enabled by a unified synthesis of diverse sulfonyl fluorides

  • Commun Chem. 2024 Oct 19;7(1):237. doi: 10.1038/s42004-024-01327-8.
Brian S Mantilla  #  1 Jack S White  #  1 William R T Mosedale  #  2 Andrew Gomm  1 Adam Nelson  3 Terry K Smith  4 Megan H Wright  5
Affiliations
  • 1. School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK.
  • 2. Schools of Biology and Chemistry, Biomedical Sciences Research Complex, University of St Andrews, St Andrews, KY16 9ST, UK.
  • 3. School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK. [email protected].
  • 4. Schools of Biology and Chemistry, Biomedical Sciences Research Complex, University of St Andrews, St Andrews, KY16 9ST, UK. [email protected].
  • 5. School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK. [email protected].
  • # Contributed equally.
Abstract

Sets of electrophilic probes are generally prepared using a narrow toolkit of robust reactions, which tends to limit both their structural and functional diversity. A unified synthesis of skeletally-diverse sulfonyl fluorides was developed that relied upon photoredox-catalysed dehydrogenative couplings between hetaryl sulfonyl fluorides and hydrogen donor building blocks. A set of 32 diverse probes was prepared, and then screened against Trypanosoma brucei. Four of the probes were found to have sub-micromolar anti-trypanosomal activity. A chemical proteomic approach, harnessing an alkynylated analogue and broad-spectrum fluorophosphonate tools, provided insights into the observed anti-trypanosomal activity, which likely stems from covalent modification of multiple protein targets. It is envisaged that the unified diversity-oriented approach may enable the discovery of electrophilic probes that have value in the elucidation of biological and biomedical mechanisms.

Products